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Abstract
Myositis ossificans in the head and neck is a rare heterotropic bone formation within a muscle.
Besides fibrodysplasia ossificans progressiva, traumatic and neurogenic forms are described in the
literature.
We are presenting the case of a 35-year-old female patient with a very rare form of MO of both
masseter muscles after 4 weeks of intensive care because of complications (critical illness
neuropathy) after chemotherapy.
Therefore, special attention should be paid to surgical trauma. As in the present case, radiotherapy,
long-time intubation with immobilization and critical myopathy and neuropathy can cause MO with
severe problems, such as trismus and reduced mouth hygiene, which can lead to reduced quality
of life.
Introduction
Myositis ossificans is a heterotropic bone formation
within a muscle. The incidence in head and neck is rare; it
is mainly found (80%) in the extremities [1]. Concerning
the head and neck, involvement of the temporal muscle
[2], the masseter muscle [3], the buccinators muscle [1],
the platysma muscle [4] and the sternocleidomastoid
muscle [5] is described. Myositis ossificans can be divided
into subtypes (Table 1). The fibrodysplasia ossificans pro-
gressiva, a rare autosomal-dominant disorder, has a prev-
alence of 1 in 2 million people and an onset in early
childhood [6].
Traumatic myositis ossificans, also called Myositis ossifi-
cans circumscripta, is the most common form, resulting in
an ossification of muscle after trauma or inflammation.
Case
A 35-year-old female patient was referred because of the
progressive decrease in the range of motion of her mandi-
ble for 2 years. Three years before, she underwent chemo-
radiotherapy because of an Epstein-Barr virus associated
nasopharyngeal carcinoma (cT4cN2bMo). After the 2cd
chemotherapy with platinol/5-FU, she developed an apla-
sia with 0.03 *103/μl leucocytes (initially 4.5). In the
course of the disease she developed several complications,
such as pseudomonas sepsis, renal insufficiency, hepat-
opathology and repeating asystole caused by cardio toxic
effect of 5-Fluorouracil. Finally she revealed a critical ill-
ness neuropathy while being intubated for 4 weeks in an
intensive care unit.
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Clinical examination revealed a strong tenderness of both
masseter muscles, anterior to the superior border of the
ramus and reaching from the zygomatic arch to the body
of the mandible without pain on palpation. Additionally,
no pain was elicited on palpation of the temporomandib-
ular joint on both sides. The maximum incisal opening
was 1 cm with limited lateral excursions (Fig. 1). Limited
intraoral examination revealed reduced mouth hygiene,
several teeth with severe dental caries, and a bony hard
mass in both buccal sulci.
The panoramic radiograph revealed an amorphous calci-
fication within the soft tissue on both sides and multiple
dental caries (Fig. 2a and Fig. 2b).
Axial and coronal computed tomography scans were
obtained of the facial skeleton, and bilateral diffuse calci-
fication of the masseter muscles without involvement of
temporal and pterygoid muscles or temporomandibular
joint on both sides was seen (Fig. 3a and Fig. 3b). A well-
circumscribed calcified mass with density similar to bone
was clearly separated from the adjacent mandibular
ramus. Laboratory data were all within normal limits.
The history of long immobilisation, in combination with
critical illness neuromyopathy, radiotherapy, clinical
examination, and radiographic findings on both masseter
muscles, was strongly suggestive of the diagnosis of
myositis ossificans. Extraction of caries teeth and an active
mouth opening were performed using anaesthetic intuba-
Table 1: Clinical subdivision of MO
Fibrodysplasia ossficans progressiva Symmetric congenital malformations of great toes, ossification of upper extremities and back
Traumatic MO Circumscript new bone growth within the muscle after injury
Neurogenic MO Occurs below spinal-cord injury
Patient with max. mouth opening Figure 1
Patient with max. mouth opening.
a. Panoramic radiograph with radiopaque mass (arrow) Figure 2
a. Panoramic radiograph with radiopaque mass 
(arrow). b. After insertion of implants
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tion (fiberoptic nasal intubation). As a second step, 8
months later, 3 implants were inserted in the upper jaw
and 4 implants in the lower jaw (Fig. 2b). Concerning tris-
mus, physical therapy and TheraBite® training have been
initiated, but the mouth opening is still unchanged (1
cm). The patient is still seen by us once a year for control
and regularly by a dental hygienist.
Discussion
The pathophysiology is still unclear. Bone morphogenetic
protein expression is discussed because of muscle trauma
resulting in stem cells differentiating into osteoblasts and
finally leading to ossification. Therefore, one treatment
strategy can be bone morphogenic protein type I receptor
inhibition in order to reduce this heterotropic ossification
[7]. Aho et al. [8] were able to show in a rabbit model that
microinjury and subsequent muscle necrosis can cause
invasion of macrophages and release osteogenic growth
factors.
Concerning the aetiology of myositis ossificans traumat-
ica of the masticatory muscles, several causes have been
described: tooth extraction associated with involvement
of the buccinator muscle [1], local anaesthesia with
involvement of the pterygoid muscle, and direct force
with myositis ossificans traumatica of the masseter. In
table 2 all cases with masseter involvement between 1954
and 2008 is presented.
Different facts are important for the development of
myositis ossificans on both masseter muscles in the
present case. On the one hand, the neurogenic compo-
nent plays an important role because of long time intuba-
tion and immobilization with incomplete pareses C3 and
critical myopathy/neuropathy (CIPNM) in an intensive
care unit. On the other hand, the traumatic/inflammatory
component plays an important role with sepsis. CIPNM
occurs in 25–63% of patients who have been on an artifi-
cial respirator for at least 1 week [9]. In patients with sep-
sis, the incidence increases, and male patients develop this
condition about twice as often as females [9].
Microcirculatory damage can reduce delivery of oxygen
and glucose and therefore affect the nervous system, lead-
ing to CIPNM with selective myosin loss in muscles fibres
and myonecrosis by inflammatory factors [10]. Factors
that are associated with the development of CIPNM can
be physical, surgical trauma, or chemicals in combination
a and b Figure 3
a and b. Calcified mass (arrow) in the masseter muscle on 
both sides.
Table 2: overview of masseter involvement between 1954 and 
2008
Author Year Masseter Side Aetiology
Yano [15] 2005 bilateral Struck on both cheeks
Aoki [16] 2002 one Struck on the cheek
Geist [17] 1998 one Mandible fracture
Myoken [18] 1998 one Trauma
Steiner [3] 1997 One Mandible fracture
one Shotgun
Lello [19] 1986 one Struck on the cheek
Arima [20] 1984 one Struck on the cheek
Christmas [21] 1982 one Fall from horse
Beck [12] 1954 bilateral Lower jaw fractureHead & Neck Oncology 2009, 1:30 http://www.headandneckoncology.org/content/1/1/30
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with sepsis and the application of neuromuscular block-
ing agents and steroids. These neuromuscular blocking
agents are metabolized by the liver and kidney [11]. If
these organs fail, as in the present case, the effect of these
blocking agents will be prolonged. Flaccid weakness of
neck flexors and facial muscles are described as a feature
in CIPNM [11], but cranial nerve involvement seems to be
rare [9]. But no case in combination with myositis ossifi-
cans has been described in the literature.
Another important factor could be the tube change with
forced mouth opening without regular oral physiotherapy
while being intubated without leading to a bleeding in an
already fibrotic muscle after previous radiotherapy.
Bilateral involvement of the masseter muscles is extremely
rare. The first case in the literature was presented in 1954
by Beck [12].
Different treatment strategies have been discussed in the
literature for myositis ossificans traumatica: surgical treat-
ment (excision), physiotherapy (including TheraBite),
medical therapy (non-steroidal anti-inflammatory drugs,
bisphosphonates and magnesium), and low-dose radia-
tion therapy [13]. Low-dose radiation therapy and non-
steroidal anti-inflammatory drugs are used in order to
inhibit mesenchymal differentiation into osteoblasts. The
use of bisphosphonates in order to prevent myositis ossi-
ficans is described in orthopaedics [14].
An excision was not an option in the present case because
of the complete involvement of both masseter muscles.
Medical therapy was not offered because the patient was
presented with a 2-year history of complaints, so the early
phase of calcification was already over. The use of etidro-
nate can also lead to osteomalzia with bisphosphonate-
associated necrosis of the jaws, so the patient did not
receive this agent.
Summary
Myositis ossificans is a rare complication that can be
caused by muscle trauma. Therefore, special attention
should be paid to surgical trauma. As in the present case,
radiotherapy, long-time intubation with immobilization
and critical myopathy and neuropathy can cause myositis
ossificans with severe problems, such as trismus and
reduced mouth hygiene, which can lead to reduced qual-
ity of life. Hence, in cases involving trismus, after a long
period of immobilisation, early intensive physiotherapy is
indicated.
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